Skip to main content
SpringerLink
Log in

A low density lipoprotein — methotrexate covalent complex and its activity against L1210 cells in vitro

  • Original Articles
  • Methotrexate, L1210 Cells
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Summary

Low-density lipoprotein particles are potential drug carriers, but only lipophilic drug species partition into the core of the system. In this paper the polar drug methotrexate has been coupled to the exterior protein of low density lipoprotein (LDL) particles using the reagent l-ethyl-3(3′-dimethylaminopropyl) carbodiimide HCl. The coupled system was sized by photon correlation spectroscopy and the in vitro activity of the complex determined against L1210 cells maintained in medium supplemented with fetal calf serum. The reaction between methotrexate and low density lipoprotein is variable but quantifiable, about ten drug molecules being attached to each LDL particle, resulting in an increase in the radius and polydispersity of the particles. The activity of the complex against L1210 murine leukaemia cells has been demonstrated in vitro, but it is 30 times less active than free drug.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Abra RM, Hunt CA, Fu KK, Peters JH (1983) Delivery of therapeutic doses of doxorubicin to the mouse, lung using lung accumulating liposomes proves unsuccessful. Cancer Chemother Pharmacol 11: 98

    Google Scholar 

  2. Armstrong SH, Budka MJE, Morrison KC, Hassan M (1947) Preparation and properties of serum and plasma proteins. XII: The refractive properties of the proteins of human plasma and certain purified factors. J Am Chem Soc 69: 1747

    Google Scholar 

  3. Arnold LJ, Dagen H, Kaplan NO (1983) Poly (L-Lysine) as an antineoplastic agent and tumour-specific drug carrier. In: Goldberg EP (ed) Targeted drugs. Wiley, p 89

  4. Carew TE, Pittman RC, Steinberg D (1982) Tissue sites of degradation of native and reductively methylated [14C]sucrose-labelled low-density lipoproteins in rats. J Biol Chem 257: 8001

    Google Scholar 

  5. Counsell RE, Pohland RC (1982) Lipoproteins as potential site-specific delivery systems for diagnostic and therapeutic agents. J Med Chem 25: 1115

    Google Scholar 

  6. Craig IF, Via DP, Mantulin WW, Pownall HJ, Gotto AM, Smith LC (1981) Low-density lipoproteins reconstituted with steroids containing nitrobenzoxadiazole fluorophore. J Lipid Res 22: 687

    Google Scholar 

  7. Deckelbaum RJ, Shipley GG, Small DM (1977) Structure and interaction of lipids in human plasma low-density lipoprotein. J Biol Chem 252: 744

    Google Scholar 

  8. Gal D, Ohashi M, MacDonald PC, Buchsbaum HJ, Simpson ER (1981 a) Low-density lipoprotein as a potential vehicle for chemotherapeutic-agents and radionuclides in the management of gynecologic neoplasms. Am J Obstet Gynecol 139: 877

    Google Scholar 

  9. Gal D, MacDonald PC, Porter JC, Simpson ER (1981 b) Cholesterol metabolism in cancer cells in monolayer culture. III: LDL metabolism. Int J Cancer 28: 315

    Google Scholar 

  10. Goldberg EP (ed) (1983) Targeted drugs, (Polymers in biology and medicine, vol 2) John Wiley

  11. Halbert GW, Stuart JFB, Florence AT (1982) Physical and biological characterisation of methotrexate-albumin conjugats. J Pharm Pharmacol [Suppl] 34: 50P

  12. Koppel DE (1972) Analysis of macomolecular polydispersity in Intensity Correlation Spectroscopy: The method of cumulants. J Chem Phys 57: 4814

    Google Scholar 

  13. Krieger M, Smith LC, Anderson RGW, Goldstein JL, Kao YJ, Pownall HJ, Gotto AM, Brown MS (1979) Reconstituted LDL: A vehicle for the delivery of hydrophobic fluorescent probes to cells. J Supramol Struct 10: 467

    Google Scholar 

  14. Kruth HS, Arigan J, Gamble W, Vaughan N (1974) Effect of cell density on binding, and uptake of low-density lipoproteins by human fibroblasts. J Cell Biol 83: 588

    Google Scholar 

  15. Lemaire M, Tillement P (1982) Role of lipoproteins and erythrocytes in the in vitro binding and distribution of cyclosporin A in the blood. J Pharm Pharmacol 34: 715

    Google Scholar 

  16. Lowry OH, Rosebrough NJ, Farr AL, Randal RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193: 265

    CAS  PubMed  Google Scholar 

  17. Margolis S, Langdon RG (1966) Studies on human serum lipoprotein. II: Chemical modification. J Biol Chem 241: 477

    Google Scholar 

  18. Mauldin J, Fisher WR (1970) pH and ionic strength-dependent aggregation of serum low density lipoprotein. Biochemistry 9: 2015

    Google Scholar 

  19. Mosley ST, Goldstern JL, Brown MS, Falck JR, Anderson RG (1981) Targeted killing of cultured cells by receptor dependent photosensitisation. P Das Biol 78: 5717

    Google Scholar 

  20. Packard CJ, Shepherd J, Joerns S, Gotto AM, Taunton PD (1979) Very low density and low density lipoprotein subfractions in type III and type IV hyperlipoproteinaemia. Biochim Biophys Acta 572: 260

    Google Scholar 

  21. Page M, Lagueux J (1983) In vitro model for the chemotherapy of leukaemia using biological function of the target cell. Eur J Cancer 19: 1307

    Google Scholar 

  22. Patsch JR, Sailer S, Kostner G, Sandhofer F, Holasak A, Braunsteiner H (1974) Separation of the main lipoprotein density classes from human plasma by rate-zonal ultracentrifugation. J Lipid Res 15: 356

    Google Scholar 

  23. Pusey P (1974) In: Cummins HZ, Pike ER (eds) Photon correlation and light beating spectroscopy. Plenum, London p 387

    Google Scholar 

  24. Rudling MJ, Collins P, Paterson CO (1983) Delivery of aclacinomycin A to human cells in vitro by the low-density lipoprotein pathway. Cancer Res 43: 4600

    Google Scholar 

  25. Seto M, Umemoto N, Saito M, Masuho Y, Hara T, Takahashi T (1982) Monoclonal antibody anti MM46: Ricin A chain conjugate: In vitro and in vivo antitumour activity. Cancer Res 42: 5209

    Google Scholar 

  26. Tucker IG, Florence AT (1983) Interactions of ionic and nonionic surfactants with plasma low-density lipoprotein. J Pharm Pharmacol 35: 705

    Google Scholar 

  27. Varga JM, Asato N, Lande S, Lerner AB (1977) Melanotropin-daunomycin conjugate shows receptor-mediated cytotoxicity in cultured melanoma cells. Nature 367: 56

    Google Scholar 

  28. Welsh J, Calman KC, Stuart F, Clegg J, Stewart JM, Packard CJ, Morgan HG, Shepherd J (1982) Low-density lipoprotein uptake by tumours. Clin Sci 63: 44P

  29. Yoshioka T, Hashida M, Muranishi S, Sezaki H (1981) Specific delivery of Mitomycin C to the liver, spleen and lung. Nanospherical carriers of gelatin. Int J Pharmacy 8: 131

    Google Scholar 

Download references

Author information

Author notes

  1. J. F. B. Stuart

    Present address: Department of Pharmacy, University of Strathclyde, G1 1XW, Glasgow, UK

Authors and Affiliations

  1. Department of Pharmacy, University of Strathclyde, G1 1XW, Glasgow, UK

    G. W. Halbert & A. T. Florence

Authors
  1. G. W. Halbert
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. F. B. Stuart
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. T. Florence
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Halbert, G.W., Stuart, J.F.B. & Florence, A.T. A low density lipoprotein — methotrexate covalent complex and its activity against L1210 cells in vitro. Cancer Chemother. Pharmacol. 15, 223–227 (1985). https://doi.org/10.1007/BF00263890

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00263890

Keywords

Search

Navigation